Email This Article
Headlines & Perspectives
AMAG's Feraheme Closer to Approval
By
Adam Feuerstein
05/01/09 - 01:04 AM EDT
All outstanding issues pertaining to the manufacturing of Feraheme, AMAG Pharmaceuticals' iron replacement therapy, have been settled to the satisfaction of the Food and Drug Administration.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,308.26 | 1,096.07 | 2,180.05 | 34.87 |
Oil *
73.22
|
|
DOWN
132.86
|
DOWN
13.11
|
DOWN
26.86
|
DOWN
1.09
|
10 Yr
3.49%
SPDR Gold
107.34
|
|
-1.27%
|
-1.18%
|
-1.22%
|
-3.03%
|
Data delayed 20 minutes |


Connect with TheStreet